Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Periodontal Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global periodontal therapeutics sector is experiencing a remarkable surge as market experts project its growth to reach an impressive $801.9 million by 2030. As per a comprehensive strategic business report, the market has demonstrated a robust compound annual growth rate (CAGR) of 8.7% starting from 2022.
Systemic Antibiotics Segment to Witness Substantial Growth The report analyzes various segments within the periodontal therapeutics market, with particular attention on systemic antibiotics, expected to chart an 8.7% CAGR. By the end of the forecast period, this segment is projected to attain a striking $623.3 million.
An in-depth examination of the market's recovery in the wake of the pandemic has led to an upward adjustment of growth forecasts for the local antibiotics segment. Experts now anticipate an 8.9% CAGR through to 2030.
Geographic Market Analysis Highlights U.S. and China as Key Players
The U.S. market is currently valued at $108.7 million and is poised for steady expansion. Meanwhile, China is emerging as a trailblazer with an expected market size of $179.2 million at an 11.6% CAGR, underscoring its significant potential in the coming years.
Beyond the U.S. and China, regions such as Japan and Canada are also shown to be growth-centric, with projected CAGRs of 5.8% and 7.1%, respectively. Europe, spearheaded by Germany, is predicted to experience a CAGR of approximately 6.7%.
Competition and Innovation: Key Market Drivers
The periodontal therapeutics landscape is characterized by robust competition with key players driving innovation. The report features 18 prominent companies that are shaping the market dynamics through their strategic initiatives. This competitive analysis is vital for stakeholders to understand their position and the market opportunities.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $410.3 Million |
| Forecasted Market Value (USD) by 2030 | $801.9 Million |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- 3M ESPE
- Align Technology, Inc.
- Bausch Health Companies Inc.
- DenMat Holdings LLC
- DENTSPLY International, Inc.
- Eli Lilly and Company
- Fibrocell Science, Inc.
- Glidewell Laboratories
- Kaken Pharmaceutical Co., Ltd.
- Mallinckrodt Pharmaceuticals
- Nobel Biocare Holding AG
- OraPharma
- Purdue Pharma LP
- Teva Pharmaceutical Industries Ltd.
- TOLMAR Pharmaceuticals, Inc.
- Ultradent Products, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/rrfssp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
